Meridian Life Science, Inc. (MLS) is a leading large scale manufacturer of immunoassay reagents including blockers, antibodies, viral antigens, recombinant proteins, PCR Enzymes, nucleotides and critical assay reagents. MLS has been providing innovative life science solutions and building trusted partnerships for over 30 years. The company's focus is to offer products and services that help to advance the development of diagnostic assays. MLS services offered include: commercial scale manufacturing of antigens and antibodies with protein purification expertise; large scale production of reagents for molecular assays; technical support with assay development experience; and contract R&D, process development, and manufacturing services to the in vitro diagnostic markets.
Bioline, a MLS company, recently launched its ready-to-use, lyophilization-compatible qPCR mix, the SensiFAST Lyo-Ready No-ROX Mix enabling researchers to lyophilize and store their real-time PCR assays at room temperature, reducing the risks associated with storage and shipping requirements. MLS services its customers from primary manufacturing operations in the USA and Europe. The Company’s shares are traded through NASDAQ’s Global Select Market, symbol VIVO. Meridian’s website address is www.meridianlifescience.com.